FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype

Laboratory Investigation

Volumn 94, Issue 7, 2014, Pages 726-739

  DeGraff, David J ^a   Grabowska, Magdalena M ^b   Case, Tom C ^b   Yu, Xiuping ^b   Herrick, Mary K ^b   Hayward, William J ^b   Strand, Douglas W ^b   Cates, Justin M ^b   Hayward, Simon W ^b   Gao, Nan ^c   Walter, Michael A ^d   Buttyan, Ralph ^e   Yi, Yajun ^b   Kaestner, Klaus H ^f   Matusik, Robert J ^a,g,h  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Rutgers University ^*  (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e VANCOUVER PROSTATE CENTRE   (Canada)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

androgen; AR; castration; FOXA; prostate; prostate cancer; prostate specific

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3ALPHA;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CASTRATION; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIUM CELL; GENE DELETION; GENE EXPRESSION; HYPERPLASIA; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MOSAICISM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; SEMINAL VESICLE; WESTERN BLOTTING;

ANIMALS; CELL DIFFERENTIATION; EPITHELIUM; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; IMMUNOHISTOCHEMISTRY; INTEGRASES; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATE; PROSTATIC HYPERPLASIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEMINAL VESICLES; TRANSCRIPTOME;

EID: 84901949987     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.64     Document Type: Article

References (41)

1. Hannenhalli S, Kaestner KH. The evolution of Fox genes and their role in development and disease. Nat Rev Genet 2009;10:233-240.
2. Lai E, Prezioso VR, Smith E, et al. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev 1990;4:1427-1436.
3. Clark KL, Halay ED, Lai E, et al. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993;364: 412-420.
4. Cirillo LA, Lin FR, Cuesta I, et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell 2002;9:279-289.
5. Yan J, Xu L, Crawford G, et al. The forkhead transcription factor FoxI1 remains bound to condensed mitotic chromosomes and stably remodels chromatin structure. Mol Cell Biol 2006;26:155-168.
6. Zaret KS, Carroll JS. Pioneer transcription factors: establishing competence for gene expression. Genes Dev 2011;25:2227-2241.
7. Mirosevich J, Gao N, Matusik RJ. Expression of Foxa transcription factors in the developing and adult murine prostate. Prostate 2005;62:339-352.
8. Gao N, Ishii K, Mirosevich J, et al. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development 2005;132:3431-3443.
9. DeGraff DJ, Yu X, Sun Q, et al. The role of Foxa proteins in the regulation of androgen receptor activity. In: Tindall DJ, Mohler JL (eds). Androgen Action in Prostate Cancer, 2008.
10. Bernardo GM, Keri RA. FOXA1: a transcription factor with parallel functions in development and cancer. Biosci Rep 2012;32:113-130.
11. Gao N, Zhang J, Rao MA, et al. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol Endocrinol 2003;17: 1484-1507.
12. Gupta A, Yu X, Case T, et al. Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2. Prostate 2013;73:582-589.
13. Yu X, Wang Y, DeGraff DJ, et al. Wnt/beta-Catenin activation promotes prostate tumor progression in a mouse model. Oncogene 2011;30: 1868-1879.
14. Grasso CS, Wu YM, Robinson DR, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012;487:239-243.
15. Barbieri CE, Bangma CH, Bjartell A, et al. The mutational landscape of prostate cancer. Eur Urol 2013;64:567-576.
16. Barbieri CE, Baca SC, Lawrence MS, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 2012;44:685-689.
17. Mirosevich J, Gao N, Gupta A, et al. Expression and role of Foxa proteins in prostate cancer. Prostate 2006;66:1013-1028.
18. Gao N, LeLay J, Vatamaniuk MZ, et al. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev 2008;22:3435-3448.
19. Wu X, Wu J, Huang J, et al. Generation of a prostate epithelial cellspecific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 2001;101:61-69.
20. Muzumdar MD, Tasic B, Miyamichi K, et al. A global double-fluorescent Cre reporter mouse. Genesis 2007;45:593-605.
21. DeGraff DJ, Clark PE, Cates JM, et al. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation. PloS one 2012;7:e36669.
22. Yu X, Wang Y, DeGraff DJ, et al. Wnt/beta-catenin activation promotes prostate tumor progression in a mouse model. Oncogene 2011;30: 1868-1879.
23. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
24. Tanner MJ, Welliver Jr. RC, Chen M, et al. Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. PLoS One 2011;6:e16027.
25. Zhang J, Gao N, DeGraff DJ, et al. Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression. Prostate 2010;70:934-951.
26. Gerhardt J, Montani M, Wild P, et al. FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer. Am J Pathol 2012;180:848-861.
27. van der Heul-Nieuwenhuijsen L, Dits NF, Jenster G. Gene expression of forkhead transcription factors in the normal and diseased human prostate. BJU Int 2009;103:1574-1580.
28. Kurita T, Lee KJ, Cooke PS, et al. Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus. Biol Reprod 2000;62:831-838.
29. Matusik RJ, Jin RJ, Sun Q, et al. Prostate epithelial cell fate. Differentiation 2008;76:682-698.
30. Gierer A. Molecular models and combinatorial principles in cell differentiation and morphogenesis. Cold Spring Harb Symp Quant Biol 1974;38:951-961.
31. Lam EW, Brosens JJ, Gomes AR, et al. Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer 2013;13:482-495.
32. Sahu B, Laakso M, Pihlajamaa P, et al. FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells. Cancer Res 2013;73:1570-1580.
33. Dodd JG, Kreis C, Sheppard PC, et al. Effect of androgens on mRNA for a secretory protein of rat dorsolateral prostate and seminal vesicles. Mol Cell Endocrinol 1986;47:191-200.
34. Harris SE, Harris MA, Johnson CM, et al. Structural characterization of the rat seminal vesicle secretion II protein and gene. J Biol Chem 1990;265:9896-9903.
35. Ostrowski MC, Kistler MK, Kistler WS. Purification and cell-free synthesis of a major protein from rat seminal vesicle secretion. A potential marker for androgen action. J Biol Chem 1979;254: 383-390.
36. Wilm B, James RG, Schultheiss TM, et al. The forkhead genes, Foxc1 and Foxc2, regulate paraxial versus intermediate mesoderm cell fate. Dev Biol 2004;271:176-189.
37. DeYoung RA, Baker JC, Cado D, et al. The orphan steroid receptor Nur77 family member Nor-1 is essential for early mouse embryogenesis. J Biol Chem 2003;278:47104-47109.
38. Sahu B, Laakso M, Ovaska K, et al. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. Embo J 2011;30:3962-3976.
39. Sasaki H, Hogan BL. Differential expression of multiple fork head related genes during gastrulation and axial pattern formation in the mouse embryo. Development 1993;118:47-59.
40. Besnard V, Wert SE, Hull WM, et al. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr Patterns 2004;5:193-208.
41. Imamura Y, Sakamoto S, Endo T, et al. FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway. PLoS One 2012;7:e42456.